Methanesulfonato{N-[2-(di-1-adamantylphosphino)phenyl]morpholine}(2'-amino-1,1'-biphenyl-2-yl)palladium(II) dichloromethane adduct, min. 98% [Mor-Dalphos Palladacycle Gen. 3]
|
|
- $68 - $204
- Product name: Methanesulfonato{N-[2-(di-1-adamantylphosphino)phenyl]morpholine}(2'-amino-1,1'-biphenyl-2-yl)palladium(II) dichloromethane adduct, min. 98% [Mor-Dalphos Palladacycle Gen. 3]
- CAS:
- MF: C43H55N2O4PPdS
- MW: 0
- EINECS:
- MDL Number:
- Synonyms:Methanesulfonato{N-[2-(di-1-adamantylphosphino)phenyl]morpholine}(2'-amino-1,1'-biphenyl-2-yl)palladium(II) dichloromethane adduct, min. 98% [Mor-Dalphos Palladacycle Gen. 3]
2 prices
Selected condition：
Brand
- Strem Chemicals
Package
- 250mg
- 1g
- ManufacturerStrem Chemicals
- Product number46-0935
- Product descriptionMethanesulfonato{N-[2-(di-1-adamantylphosphino)phenyl]morpholine}(2'-amino-1,1'-biphenyl-2-yl)palladium(II) dichloromethane adduct, min. 98% [Mor-Dalphos Palladacycle Gen. 3]
- Packaging250mg
- Price$68
- Updated2021-12-16
- Buy
- ManufacturerStrem Chemicals
- Product number46-0935
- Product descriptionMethanesulfonato{N-[2-(di-1-adamantylphosphino)phenyl]morpholine}(2'-amino-1,1'-biphenyl-2-yl)palladium(II) dichloromethane adduct, min. 98% [Mor-Dalphos Palladacycle Gen. 3]
- Packaging1g
- Price$204
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Strem Chemicals | 46-0935 | Methanesulfonato{N-[2-(di-1-adamantylphosphino)phenyl]morpholine}(2'-amino-1,1'-biphenyl-2-yl)palladium(II) dichloromethane adduct, min. 98% [Mor-Dalphos Palladacycle Gen. 3] | 250mg | $68 | 2021-12-16 | Buy |
| Strem Chemicals | 46-0935 | Methanesulfonato{N-[2-(di-1-adamantylphosphino)phenyl]morpholine}(2'-amino-1,1'-biphenyl-2-yl)palladium(II) dichloromethane adduct, min. 98% [Mor-Dalphos Palladacycle Gen. 3] | 1g | $204 | 2021-12-16 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|